Publications by authors named "Shaobo Hong"
Front Pharmacol
July 2020
Article Synopsis
- Dioscin shows promise as an anticancer agent against prostate cancer (PCa), but its mechanism of action is not fully understood.
- The study indicates that dioscin may inhibit PCa growth by targeting the SHP1 protein, leading to increased SHP1 phosphorylation and disruption of the P38 signaling pathway.
- Dioscin also promotes apoptosis in PCa cells, suggesting its potential as a future treatment for both androgen-sensitive and androgen-independent forms of the disease.
